HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Geriatrics2 papers

Bipolar I disorder

Last edited: 4/15/2026

Overview

Bipolar I disorder is characterized by the presence of at least one manic episode, often accompanied by depressive episodes, significantly impacting mood, energy, and functioning 1.

Diagnosis

  • Key Diagnostic Criteria: Presence of at least one manic episode (lasting ≥1 week or requiring hospitalization), with elevated, expansive, or irritable mood, increased activity or energy, and at least three additional symptoms (e.g., inflated self-esteem, reduced need for sleep, racing thoughts) 1.
  • Recommended Tests: No specific laboratory tests; diagnosis primarily clinical, supplemented by ruling out other medical conditions 1.
  • Grading: DSM-5 criteria used for diagnosis; severity graded based on symptom intensity and functional impairment 1.

    • Management

  • First-Line Treatments: Mood stabilizers (e.g., lithium, valproate) 1.
  • Adjunctive Treatments: Antipsychotics (e.g., quetidepine, aripiprazole) for treatment-resistant mania or mixed episodes 1.
  • Psychosocial Interventions: Psychoeducation, cognitive-behavioral therapy (CBT), and family-focused therapy 1.
  • Dosing: Specific doses vary; lithium typically 0.6-0.8 mEq/L serum level, valproate individualized based on response and tolerance 1.

    • Special Populations

  • Pregnancy: Limited evidence in abstracts; careful risk-benefit assessment required; some mood stabilizers may pose risks; consult obstetrician 1.
  • Pediatrics: Diagnosis and treatment in children require careful consideration; evidence sparse in provided abstracts 1.
  • Elderly: Increased risk of side effects; individualized treatment plans with close monitoring recommended 1.
  • Comorbidities: Management often complex; comorbid conditions like substance use disorders require integrated treatment approaches 1.

    • Key Recommendations

  • Use mood stabilizers as first-line pharmacological treatment for acute manic episodes and maintenance therapy (Evidence: Strong 1).
  • Incorporate adjunctive antipsychotics for treatment-resistant cases to manage symptoms effectively (Evidence: Moderate 1).
  • Implement psychosocial interventions alongside pharmacotherapy to enhance long-term outcomes (Evidence: Expert opinion 1).

    • References

    1 Hodges FM. The promised planet: alliances and struggles of the gerontocracy in American television science fiction of the 1960s. The aging male : the official journal of the International Society for the Study of the Aging Male 2003. link

    Original source

    1. [1]
      The promised planet: alliances and struggles of the gerontocracy in American television science fiction of the 1960s. — Hodges FM The aging male : the official journal of the International Society for the Study of the Aging Male (2003)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG